Literature DB >> 24318294

Mystical and archetypal experiences of terminal patients in DPT-assisted psychotherapy.

W A Richards1.   

Abstract

Entities:  

Year:  1978        PMID： 24318294     DOI： 10.1007/BF01532413

Source DB:  PubMed          Journal:  J Relig Health        ISSN： 0022-4197


× No keyword cloud information.
  2 in total

1.  Implications of LSD and experimental mysticism.

Authors:  W N Pahnke; W A Richards
Journal:  J Relig Health       Date:  1966-07

2.  Clinical evaluation of some hallucinogenic tryptamine derivatives.

Authors:  L A Faillace; A Vourlekis; S Szara
Journal:  J Nerv Ment Dis       Date:  1967-10       Impact factor: 2.254
  2 in total
  6 in total

1.  Near-death experience: A review from pastoral psychology.

Authors:  W S Sabom
Journal:  J Relig Health       Date:  1980-06

Review 2.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

Review 3.  Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.

Authors:  Sam G Moreton; Luke Szalla; Rachel E Menzies; Andrew F Arena
Journal:  Psychopharmacology (Berl)       Date:  2019-11-29       Impact factor: 4.530

Review 4.  New Paradigms of Old Psychedelics in Schizophrenia.

Authors:  Danish Mahmood; Sattam K Alenezi; Md Jamir Anwar; Faizul Azam; Kamal A Qureshi; Mariusz Jaremko
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-23

5.  Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.

Authors:  Maggie Kamila Kiraga; Kim P C Kuypers; Malin Vedoy Uthaug; Johannes G Ramaekers; Natasha Leigh Mason
Journal:  Front Psychiatry       Date:  2022-07-07       Impact factor: 5.435

6.  Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.

Authors:  Leor Roseman; David J Nutt; Robin L Carhart-Harris
Journal:  Front Pharmacol       Date:  2018-01-17       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.